OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Critical Reviews in Toxicology (2020) Vol. 50, Iss. 5, pp. 359-382
Closed Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

The synthetic cannabinoids menace: a review of health risks and toxicity
Ayman Alzu’bi, Fatimah Almahasneh, Ramada R. Khasawneh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 21

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Kenneth B. Walsh, Amanda E. McKinney, Andrea E. Holmes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 95

Synthetic Cannabinoids: A Pharmacological and Toxicological Overview
Rita Roque Bravo, Rafaela Sofia Silva, R.F. Malheiro, et al.
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 187-209
Open Access | Times Cited: 46

An emerging trend in Novel Psychoactive Substances (NPSs): designer THC
Cristian Caprari, E. Ferri, Maria Angela Vandelli, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 13

The why behind the high: determinants of neurocognition during acute cannabis exposure
Johannes G. Ramaekers, Natasha L. Mason, Lilian Kloft, et al.
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 7, pp. 439-454
Closed Access | Times Cited: 54

Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study
Valerio Ricci, Franca Ceci, Francesco Di Carlo, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109118-109118
Closed Access | Times Cited: 42

Synaptic changes induced by cannabinoid drugs and cannabis use disorder
Shana M. Augustin, David M. Lovinger
Neurobiology of Disease (2022) Vol. 167, pp. 105670-105670
Closed Access | Times Cited: 26

New Psychoactive Substances: Health and Legal Challenges
I.C.S. Santos, Daniela Maia, Ricardo Jorge Dinis‐Oliveira, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 285-302
Open Access | Times Cited: 5

The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access

Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures
Enrique Estudillo, Jorge Iván Castillo-Arellano, Emilio G. Martínez, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 70-70
Open Access

Evaluating Delta-8-THC–Induced Psychosis: A Systematic Review
Megan Jayne Ralston, Alim Osman
Clinical Neuropharmacology (2025) Vol. 48, Iss. 1, pp. 20-23
Closed Access

Uncovering the Metabolic Footprint of New Psychoactive Substances by Metabolomics: A Systematic Review
Ana Sofia Almeida, Paula Guedes de Pinho, Fernando Remião, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 290-290
Open Access

Involuntary intoxication caused by vaping the synthetic cannabinoid ADB-BUTINACA: a case report
Elise M. A. Slob, Maryam Lyousoufi, S. T. Pasha, et al.
Toxicology Reports (2025), pp. 101930-101930
Open Access

Synthetic Cannabinoid Use Among Noninstitutionalized Individuals in the United States, 2021-2023
Joseph J. Palamar, Nina Abukahok, Austin Le
Drug and Alcohol Dependence (2025) Vol. 270, pp. 112603-112603
Closed Access

Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-Cigarettes
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
ACS Omega (2025)
Open Access

Cannabinoids-Induced Rhabdomyolysis in a Patient: A Report of a Case and a Review of Literature
Sultan AlKhateeb, Bashaer Albulushi, Khaled Joueidi, et al.
Cureus (2025)
Open Access

ANÁLISE EPIDEMIOLÓGICA DO CRESCIMENTO DO USO DE CANABINÓIDES SINTÉTICOS NO MUNICÍPIO DE SÃO PAULO
Shayna Aguiar Santana
BEPA Boletim Epidemiológico Paulista (2025) Vol. 22, pp. 1-14
Closed Access

Prevalence and Patterns of Cannabis Product Adulteration: An Analysis of WEDINOS Data
Simon Erridge, Martin Hall, Mikael H. Sodergren
Journal of Psychoactive Drugs (2025), pp. 1-7
Open Access

The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Mariarosaria Ingegneri, Erika Smeriglio, Younes Zebbiche, et al.
Toxics (2025) Vol. 13, Iss. 4, pp. 247-247
Open Access

Simultaneous enrichment and ultra-high sensitivity detection of multi-structural synthetic cannabinoids in large-volume wastewater
Rui Cao, Jiawei Chen, Ningjia Pang, et al.
Microchimica Acta (2025) Vol. 192, Iss. 5
Closed Access

HPLC Method for Novel Cannabinoid Separation with Electrochemical Detection on Boron-Doped Diamond Electrode
Zeynab Belbasi, Jan Petr, Jan Hrbáč, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116875-116875
Closed Access

Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top